TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
UROY

Uranium Royalty Corp

Energy · Uranium · listed since 2021

4.10$ -0.5% vs. previous close Closing price · As of: Aug 13, 2026
🔔 Watch stock
Add to watchlist

Stock Watch

Stock Watch will tell you what changes at Uranium Royalty Corp.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 2.60 $ to 5.50 $ · Last price: 4.10 $ (As of: August 13, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 1.6$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. –
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. –
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. –

Performance

Perf. 1M ?Price performance over the last month. 57.40%
Perf. 3M ?Price performance over the last 3 months. -4.40%
Perf. 6M ?Price performance over the last 6 months. -0.50%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 17.80%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -23.6%
Perf. 1Y ?Price performance over the last 12 months. 56.54%
Perf. 3Y ?Price performance over the last 3 years. 80.89%
Perf. 5Y ?Price performance over the last 5 years. 61.97%
Perf. Since Inception ?Price performance since the first available trading day (01/14/2020) — with a complete history, that is since the IPO. 341.53%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 3.10$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 3.10$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 3.70$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 71.4
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 75.0%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 74.9%

Calculated from the price history · as of 08/14/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. 14.0
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. –
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. –
P/B ?Price-to-book ratio: market value relative to book equity. 4.9
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 6.1
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. –
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 6.7

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. –
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. 32.1%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. –
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 15.3%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). –

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. 83.8%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.00
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. fortress balance sheet 13.61
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 6 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 4,342.60%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 462.20%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 1,553.75%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. -100.00%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. -96.70%

Dividend

No dividend data is available for this stock yet.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. –
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. –
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. –
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (62 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Uranium

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Uranium Royalty Corp UROY 1.6 14.0 – – 32.1 1,553.8 56.5
Uranium Energy Corp UEC 5.5 – 186.7 -396.0 -629.7 29,738.0 9.5
Centrus Energy Corp. LEU 3.9 – 31.6 25.7 -0.3 1.5 2.3
Energy Fuels Inc UUUU 3.7 – -21.1 34.6 -40.6 -15.6 53.3
Eagle Nuclear Energy Corp. NUCL 0.2 – – – 0.0 – -35.2
Anfield Energy Inc. AEC 0.1 – – – 0.0 – -20.3
Median of companies shown 2.6 – 31.6 25.7 -0.1 777.6 5.9

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q3 · 0.0 $M Q3 2024: Q4 · 10.9 $M Q4 2025: Q1 · 0.0 $M Q1 2025: Q2 · 4.7 $M Q2 2025: Q3 · 33.2 $M Q3 2025: Q4 · 0.0 $M Q4 2026: Q1 · 16.7 $M Q1 2026: Q2 · 204.3 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q3 -0.01 -66.70 0 -100.00 – -12 -18
2024: Q4 0.00 -111.60 11 -28.80 -3.90 -11 -17
2025: Q1 -0.01 -146.30 0 -100.00 -47,775.00 -2 -2
2025: Q2 -0.01 -129.30 5 -61.70 -24.70 2 1
2025: Q3 0.01 176.90 33 – 4.60 23 22
2025: Q4 0.02 869.20 0 -99.60 4,959.70 -2 -2
2026: Q1 0.01 200.00 17 417,056.10 11.80 7 7
2026: Q2 -0.01 0.00 204 4,257.00 24.50 206 206

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 1 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings –
Price Target (average) –
Distance to price –

No price target is available for this stock.

AI classification

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.

How the Rating Is Built

The company

About the Company

Uranium Royalty Corp. ist als Unternehmen für Uran- und Landlizenzen in Kanada tätig. Es befasst sich mit dem Erwerb und Aufbau eines Portfolios von Lizenzgebühren, Investitionen in Unternehmen mit Uran- und Physischem-Uran-Exposure sowie dem Kauf und Verkauf von physischem Uran. Das Unternehmen wurde 2017 gegründet und hat seinen Sitz in Lakewood, Colorado.

IPO Year
2021
ISIN
US91703D1000

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?